EvoGenix in-licenses DiNonA antibody

Diagnostic company DiNonA (Seoul, South Korea) granted EvoGenix (ASX:EGX) worldwide rights to humanize and develop a mouse antibody to treat adult leukemia. The deal excludes Asia. DiNonA is eligible ...